4.62
price down icon12.08%   -0.635
 
loading
Precedente Chiudi:
$5.255
Aprire:
$5.41
Volume 24 ore:
160.18K
Relative Volume:
2.83
Capitalizzazione di mercato:
$30.58M
Reddito:
$5.75M
Utile/perdita netta:
$-38.96M
Rapporto P/E:
-0.3705
EPS:
-12.47
Flusso di cassa netto:
$-32.63M
1 W Prestazione:
+14.36%
1M Prestazione:
+13.79%
6M Prestazione:
-33.81%
1 anno Prestazione:
-28.37%
Intervallo 1D:
Value
$4.36
$5.90
Intervallo di 1 settimana:
Value
$3.8217
$5.90
Portata 52W:
Value
$2.92
$11.20

Kala Bio Inc Stock (KALA) Company Profile

Name
Nome
Kala Bio Inc
Name
Telefono
781-996-5252
Name
Indirizzo
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Name
Dipendente
38
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
KALA's Discussions on Twitter

Confronta KALA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
KALA
Kala Bio Inc
4.62 30.58M 5.75M -38.96M -32.63M -12.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Kala Bio Inc Stock (KALA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-03-30 Downgrade JP Morgan Neutral → Underweight
2021-08-06 Downgrade JP Morgan Overweight → Neutral
2020-09-14 Downgrade Jefferies Buy → Hold
2020-07-23 Iniziato Northland Capital Outperform
2020-06-01 Ripresa Oppenheimer Outperform
2020-05-27 Reiterato H.C. Wainwright Buy
2020-03-09 Aggiornamento BofA/Merrill Neutral → Buy
2019-12-17 Downgrade BofA/Merrill Buy → Neutral
2019-03-14 Iniziato Jefferies Buy
Mostra tutto

Kala Bio Inc Borsa (KALA) Ultime notizie

pulisher
Jun 06, 2025

Millennium Management LLC Purchases 17,130 Shares of HBT Financial, Inc. (NASDAQ:HBT) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Millennium Management LLC Decreases Stake in KALA BIO, Inc. (NASDAQ:KALA) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Nexa Resources S.A. (NYSE:NEXA) Shares Sold by Millennium Management LLC - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

24,353 Shares in T. Rowe Price Floating Rate ETF (NYSEARCA:TFLR) Acquired by Bank of America Corp DE - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Cadre Holdings, Inc. (NYSE:CDRE) Shares Acquired by Millennium Management LLC - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Bank of America Corp DE Acquires 2,612 Shares of First Trust Indxx Global Natural Resources Income ETF (NASDAQ:FTRI) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Millennium Management LLC Sells 1,791 Shares of Bluerock Homes Trust, Inc. (NYSEAMERICAN:BHM) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Ameriprise Financial Inc. Buys 11,012 Shares of Liberty All-Star Growth Fund, Inc. (NYSE:ASG) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Kala Bio director Mark Iwicki sells $40,638 in stock By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Kala Bio director Mark Iwicki sells $40,638 in stock - Investing.com India

Jun 05, 2025
pulisher
Jun 04, 2025

KALA BIO Executives Sell Shares - TradingView

Jun 04, 2025
pulisher
Jun 04, 2025

Pre-market Movers: STSS, SGMT, NIVF, OGEN... - RTTNews

Jun 04, 2025
pulisher
Jun 03, 2025

KALA BIO (NASDAQ:KALA) Given “Outperform” Rating at Oppenheimer - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

KALA: Oppenheimer Announces Outperform Rating for Kala Bio | KALA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

KALA Stock Gains Momentum with Oppenheimer's Positive Outlook | - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

KALA Stock Gains Momentum with Oppenheimer's Positive Outlook | KALA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 01, 2025

Tidal Investments LLC Has $269,000 Stake in Air Lease Co. (NYSE:AL) - Defense World

Jun 01, 2025
pulisher
Jun 01, 2025

Aegon Ltd. (NYSE:AEG) Shares Sold by Millennium Management LLC - Defense World

Jun 01, 2025
pulisher
May 29, 2025

KALA BIO to Present at Jefferies Global Healthcare Conference - The Manila Times

May 29, 2025
pulisher
May 29, 2025

KALA BIO to Reveal Latest Eye Disease Pipeline Progress at Major Jefferies Healthcare Conference - Stock Titan

May 29, 2025
pulisher
May 26, 2025

Q1 Earnings Estimate for KALA BIO Issued By HC Wainwright - Defense World

May 26, 2025
pulisher
May 25, 2025

HC Wainwright Lowers KALA BIO (NASDAQ:KALA) Price Target to $12.00 - Defense World

May 25, 2025
pulisher
May 24, 2025

Kala Bio stock target cut to $12 by H.C. Wainwright, retains buy - Investing.com Nigeria

May 24, 2025
pulisher
May 23, 2025

KALA Stock: HC Wainwright & Co. Adjusts Price Target for Kala Bi - GuruFocus

May 23, 2025
pulisher
May 23, 2025

KALA Stock: HC Wainwright & Co. Adjusts Price Target for Kala Bio | KALA Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

KALA Price Target Reduced by H.C. Wainwright After Q3 Results | - GuruFocus

May 23, 2025
pulisher
May 23, 2025

KALA Price Target Reduced by H.C. Wainwright After Q3 Results | KALA Stock News - GuruFocus

May 23, 2025
pulisher
May 15, 2025

KALA BIO: Q1 Earnings Snapshot - New Haven Register

May 15, 2025
pulisher
May 14, 2025

Persistent Epithelial Defect Market on Track for Major - openPR.com

May 14, 2025
pulisher
May 14, 2025

KALA Focuses on Advancing KPI-012 Development Amid Pivotal Trials | KALA Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Kala Pharmaceuticals reports Q1 EPS ($1.41) vs ($4.20) last year - TipRanks

May 14, 2025
pulisher
May 14, 2025

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Algorhythm Holdings to Announce its Financial Results for the First Quarter 2025 - The Manila Times

May 14, 2025
pulisher
May 14, 2025

KALA's PCED Drug Could Reach 100,000 PatientsQ3 Trial Results Coming - Stock Titan

May 14, 2025
pulisher
May 12, 2025

Q2 EPS Forecast for Design Therapeutics Reduced by Analyst - Defense World

May 12, 2025
pulisher
May 12, 2025

Research Analysts Set Expectations for Datadog Q2 Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

B. Riley Issues Negative Estimate for Cadre Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

HC Wainwright Issues Positive Forecast for Clene Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

Equities Analysts Issue Forecasts for Cryoport Q2 Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

B. Riley Forecasts Lower Earnings for Denali Therapeutics - Defense World

May 12, 2025
pulisher
May 12, 2025

Q2 EPS Estimate for Cogent Biosciences Lifted by Analyst - Defense World

May 12, 2025
pulisher
May 12, 2025

Q2 EPS Estimates for Core Scientific Lifted by HC Wainwright - Defense World

May 12, 2025
pulisher
May 12, 2025

B. Riley Issues Negative Estimate for Fox Factory Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

KALA BIO (KALA) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 12, 2025
pulisher
May 12, 2025

Q2 Earnings Forecast for Cryoport Issued By Leerink Partnrs - Defense World

May 12, 2025
pulisher
May 11, 2025

KALA BIO (KALA) Projected to Post Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 08, 2025

Fluence Energy, Inc. (NASDAQ:FLNC) Shares Acquired by Dimensional Fund Advisors LP - Defense World

May 08, 2025
pulisher
May 07, 2025

Dimensional Fund Advisors LP Sells 5,772 Shares of Turning Point Brands, Inc. (NYSE:TPB) - Defense World

May 07, 2025
pulisher
May 04, 2025

Head-To-Head Survey: Equillium (NASDAQ:EQ) and KALA BIO (NASDAQ:KALA) - Defense World

May 04, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Has $426,000 Stake in Sidus Space, Inc. (NASDAQ:SIDU) - Defense World

May 03, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Increases Position in Forte Biosciences, Inc. (NASDAQ:FBRX) - Defense World

May 03, 2025

Kala Bio Inc Azioni (KALA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Kala Bio Inc Azioni (KALA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Reumuth Mary
CHIEF FINANCIAL OFFICER
Jun 24 '25
Sale
4.01
3,631
14,560
62,100
Bazemore Todd
SEE REMARKS
Jun 24 '25
Sale
4.01
4,058
16,273
83,699
Brazzell Romulus K
SEE REMARKS
Jun 24 '25
Sale
4.01
5,251
21,057
82,698
Iwicki Mark T
Director
Jun 24 '25
Sale
4.01
13,227
53,040
258,433
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Capitalizzazione:     |  Volume (24 ore):